NPCE logo

NPCE

Neuropace Inc.

$14.35
-$0.21(-1.44%)
42
Overall
40
Value
36
Tech
52
Quality
Market Cap
$464.98M
Volume
128.89K
52W Range
$7.56 - $18.98
Target Price
$19.50

Company Overview

Mkt Cap$464.98MPrice$14.35
Volume128.89KChange-1.44%
P/E Ratio-17.1Open$14.74
Revenue$79.9MPrev Close$14.56
Net Income$-27.1M52W Range$7.56 - $18.98
Div YieldN/ATarget$19.50
Overall42Value40
Quality52Technical36

No chart data available

About Neuropace Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides Physician Tablet, Patient Data Management System, and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Latest News

Analysts Are Bullish on Top Healthcare Stocks: Glaukos (GKOS), Rapid Micro Biosystems (RPID)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Glaukos (GKOS – Research Report), Rapid Micro Biosys...

Brian Andersona month ago
ABCD
1SymbolPriceChangeVol
2NPCE$14.35-1.4%128.89K
3
4
5
6

Get Neuropace Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.